{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:23:20Z","timestamp":1698679400047},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T00:00:00Z","timestamp":1297036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p>Afrin LB, Afrin JB. Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration.\u2028Clin Transplant 2011: 25: E271\u2013E275. \u00a9 2011 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold>  <jats:italic>Pneumocystis jirovecii<\/jats:italic> prophylaxis is standard in allogeneic stem cell transplantation (alloSCT), sometimes with pentamidine at a low dose inhaled monthly. Human metabolism of pentamidine depends on cytochrome P450 2C19 (CYP2C19). The frequency of mutant CYP2C19 forms with decreased function (from 2% of Caucasians to 30% of Asians and 79% of certain Polynesians), together with common use of CYP2C19 inhibitors in the alloSCT process, creates risk for impaired pentamidine clearance resulting in toxicity ordinarily expected only with high doses given for active infection. We examined the charts of 32 consecutive pentamidine\u2010prophylaxed alloSCT patients at our center. We assessed hospital charges for the management of toxicities unexplained at the time but likely attributable, in retrospect, to pentamidine. Twenty\u2010eight percent experienced significant toxicities (incurring added charges of at least US$5000). Thirteen percent suffered major toxicity (incurring added charges of at least US$25\u2003000; median added charge $351\u2003701) and shorter survival (326 vs. 622\u2003d for all pentamidine recipients), including 6% who died of pentamidine toxicities [one proven postmortem to have a (non\u2010functional) homozygous CYP2C19*2 mutation]. Charges for care attributable to pentamidine toxicity exceeded what preemptive genotyping would have cost by 73\u2010fold. These findings encourage routine use of preemptive CYP2C19 genotyping in alloSCT patients considered for pentamidine.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2011.01399.x","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T03:32:36Z","timestamp":1297135956000},"source":"Crossref","is-referenced-by-count":3,"title":["Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration"],"prefix":"10.1111","volume":"25","author":[{"given":"Lawrence B.","family":"Afrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica B.","family":"Afrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,7]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"1","article-title":"Pneumocystis carinii pneumonia opportunistic infection in stem cell transplant: 2000 CDC recommendations","volume":"49","author":"Dykewicz CA","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_8_3_2","unstructured":"Drugdex[database on the Internet].Thomson Healthcare; \u00a9 1974\u20102010. Drugdex Evaluations \u2010 Pentamidine http:\/\/www.thomsonhc.com\/micromedex2\/librarian\/ND_P\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=pentamidine last accessed November 12 2010."},{"key":"e_1_2_8_4_2","first-page":"167","article-title":"Cytochromes P450 \u2013 their impact on drug treatment","volume":"9","author":"Tredger JM","year":"2002","journal-title":"Hospital Pharmacist"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/019262339602400107"},{"key":"e_1_2_8_6_2","unstructured":"SimSC for the Human Cytochrome P450 (CYP) Allele Nomenclature Committee.CYP2C19 Allele Nomenclature. Available on\u2010line athttp:\/\/www.cypalleles.ki.se\/cyp2c19.htm last accessed November 12 2010."},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.10.002"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.815"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01213011-199910000-00005"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241120-00002"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705786"},{"key":"e_1_2_8_12_2","unstructured":"MayoMedicalLaboratories.Unit Code 60439: Cytochrome P450 2C19 Genotype by Sequence Analysis: Fees and Coding. Available athttp:\/\/www.mayomedicallaboratories.com\/test\u2010catalog\/Fees+and+Coding\/60439 last accessed November 12 2010."},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.5.985"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2011.01399.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2011.01399.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:37:34Z","timestamp":1697380654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2011.01399.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,7]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1399-0012.2011.01399.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01399.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,7]]}}}